$NNNN News

US Market's Hidden Gems: 3 Promising Small Caps

Discovering 3 US Small Cap Gems with Promising Potential

US Undiscovered Gems to Watch in April 2026

Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up

Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Anbio Biotechnology's Hype And Hard Approvals Suggest A Stretched Valuation

Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

Anbio Biotechnology (NASDAQ:NNNN) Has A ROE Of 14%

Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN)

Anbio Biotechnology: Risky Valuation Concerns As COVID-Related Sales Decline

Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions

Anbio Biotechnology Announces Closing of Initial Public Offering

Anbio Biotechnology Shares Open For Trade At $5.26/Share; IPO Priced At $5/Share On 1.6M Shares

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Anbio Biotechnology Announces Pricing of Initial Public Offering

Preview: Anbio Biotechnology Set To IPO Tomorrow

Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch